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THiF, interceHular ground substance of some virus-induced fowl sarcomas is
unusuaRy viscous and shows, after histological processing, basophihc and meta-
chromatic staining properties. Varying degrees of metachromasia to basic
anihne dyes have been noted, and the reaction is diminished after digestion of
the viscous material with testis hyaluronidase. Previous extraction experi-
ments mentioned below indicated a high content of hyaluronate in the ground
substance, but other- observations on tumours, however, suggested the 8iMUl-
taneou8presence of ester sulphate-bearing polysaccharides (Sylve'n, 1945, 1949).
Since the composition of stromal polysaccharides is larLrelv unknown, the results
of a more detailedreinvestigation will be brieflyreported.
Kabat (1939) isolated from two cystic fowl sarcomas a polysaccharide closely
similar to umbifical cord hyaluronic acid, and Claude (1940) reported that leech
hyaluronidase reduced the viscosity of Rous chicken tumour extracts. Pirie
(1942) obtained hyaluronic acid from Rous and Fujinami myxosarcomas; this
was in two cases stated to be free fromsulphur, in one case, however, the prepara-
tion contained additional nitrogen and also 0-1 per cent sulphur. Warren,
Wilhams, Album and Seifter (1949) obtained from fresh Rous chicken sarcomas
a yield of about 0-1 per cent ofhyaluronic acid of moderate purity (N, 3-8 per
cent). This acid had alowerviscositythanthoseusuallyobtainedfrom umbilical
cord.
EXPERIMENTAL.
Extraction and characterization of the crude poly8accharides.
Tumour was collected from 2 to 3 months old Brown Leghorn fowls bearing
rapidly-growing pectoral Rous sarcomas. Care was taken to avoid necrotic
areas and possible admixture of cartilage. The pooled material was defatted in
cold acetone, dried and extracted for 3 days at room temperature in 2 per cent
phenol solution. The centrifugaRy-cleared extract was adjusted to I per cent
with 20 per cent saline and the crude mucoprotein, etc., precipitated by addition
of two volumes of alcohol. The washed deposit was redissolved in 1 per cent
saline,adjusted topH 7-5,anddigestedfor 24 hours at roomtemperaturewith com-
mercial trypsin. The mixture was then filtered with the aid of Hyflo Super-cel
and reprecipitated with 2 volumes of alcohol. The deposit was again washedwith aqueous alcohol and finaRy redissolved in water. Low molecular weight
contaminants were removed by dialysis for 96 hours against water at 2' C. The
viscous polysaccharide solution was finaRy centrffuged for 2 hours at 2'C. and
20,000 r.p.m. (Spinco preparative ultra-centrifuge) and the clear supematant
frozen-dried. The yield of protein-free, crude polysaccharide was about 2 per
cent of the acetone-dried tumour tissue.
The material containedpolysaccharide andpentosenucleicacid, andtheanaly-
tical data were: Nitrogen (Kjeldahl) varying between 5-2 and 6-3 per cent ;
Phosphorus (Fiske and Subbarow) 1-7 to 1-8 per cent; and Sulphur (Paulson)
0-6 per cent. The ninhydrin reaction was negative. Metachromatic sta'm'mg
withAzureA(Sylv6n andMalmgren, 1952) revealed the presence of one orthochro-
matic component and anotherpresenting alcohol-resistant metachromatic precipi-
tates. The material had no anti-thrombic activity, indicating that heparin in
a free state was not present. The viscous material was further degraded by
testis hyaluronidase at a somewhat slower rate than purified umbilical hyaluron-
ate. In the ultracentrifuge, one inhomogeneous component was found. The
electrophoresis experiments indicated the presence of two components with high
electrophoretic mobilities (Table I and Fig. 1, upper curve).
FiG. I.-Electrophoresis diagram of sample A (above), and sample D (below). The left
peaks are false boundaries, the main peaks are due to hyaluronic acid, and the right peak
ofsample A is due to nucleic acid. Arrow indicates direction ofmigration.
Preliminary experiments showed that the phosphorus-containing component
of this crude polysaccharide was largely pentosenucleic acid. After hydrolysis
of the mixture with 0-2 N sodium hydroxide 96 per cent of the total phosphorus
was rendered acid-soluble. Substitution of crystalline for commercial-grade
tryps'm in the extraction procedure gave final products containing 8-9 per cent
N and 3-4 per cent P. Enzymatic hydrolysis of the main polysaccharide com-
ponent of the mixture in an early stage of the extraction permitted the purifica-
tion of this pentosenucleic acid, and it was subsequently analysed for its pentose
nucleoside content (Beale, Harris and Roe, 1952).
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Purification procedure.
In order to get rid of the nucleic acid and sulphur-bearing admixtures for this
investigation the following purification scheme was adopted:
Purification Scheme of Crude Rous Pol saccharide.
Rous crude polysaccharide (A) (200 mg.).
Ribonuclease (1-2 mg.) treatment in borate buffer at pH 7-7 at 30' for 48 hours, followed by
dialysis.
Dialysis residue (B) dried in vacuo from the frozen state (152 mg.).
100 mg. of B digested with 0-5 mg. desoxyribonuclease in borate buffer at pH 7-0 for 48 hours,
followed by dialysis.
Addition of Azure A to the bulk of the dialysis residue.
The metachromatic precipitate removed by means of Spinco ultracentrifuge (60 min. run at 30,000
r.p.m.).
Excess ofdye removed by ion exchanger (Dowex 50).
The filtrate dried in vacito in the frozen state.
Yield ofpurified material (D) 70 mg.
Part of the dialysis residue (C) dried in vacuo from the frozen state. Yield 22 mo'.0
Samples A, B, C and D were analysed for nitrogen, phosphorus, sulphur
(Paulson, 1953), hexosamine (Blix, 1948), and hexuronic acid (Maher, 1949).
Ultracentrifugation experiments were performed at a concentration of 0-5 per
cent in 0-Ilt phosphate buffers at pH 6-8, and electrophoretic investigations at
a concentration of 0-25 per cent in 0-Ilt acetate buffers at pH 4-2. The data
obtained are given in Table I together with, for comparison, data on highly-
purified sodium hyaluronate.
TABLE 1.
Hyaluronic
acid from
human umbilical
cord
A. B. C. D. (Na salt).
Nitrogen in per cent. 5- 26 3 11 3 15 3 29 3
- 24
Phosphorus I- 76 0- 05 0 06 0.00
Sulphur 0- 61 0- 80 0.01 <0-02
Hexosamine 31- 9 43
- 0 42 2 44
- 4
Hexuronie acid 35 7 46.9 48 I
Electrophoretic mobility 10- 4 9.9 9. 9 9.0
X 105 CM.2/Volt sec. 13
- 8
Sedimentation constant 1- 13 1- 08 O- 98
X 1013 C.g.S.
Optical rotation [a]
20 440 -35' to -40'* D 730t
According to Sylv6n and I%Ialmgren (1952).
t According to Meyer and Chaffee (1940) on synovial hyaluronic acid.
The first purification step, namely, digestion with crystalline ribonuclease,
converted about 25 per cent of the crude material A into a dialysable form.
Calculated on the P value, the intermediate sample B still contained, however,
about 3 per cent of the total nucleic acid originally present in sample A. This
evidently could not be removed by desoxyribonuclease since the same P contents0
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were found in samples B and C, and this residue may possibly be a part of the
ribosenucleic acid not attackedby ribonuclease, and stifpresent in the finalpoly-
saccharide material D. After ribonuclease treatment the fastest moving compo-
nent in the electrophoretic pattem (#
= 13-8) had disappeared (Fig. 1, lower
part). The sedimentation diagrams of samples A and B were, however, quite
similar showing only one component sedimenting with the same velocity.
The sulphur-bearing admixture in sample B was removed almost completely
by precipitation with Azure A (ep, Sylve'n and Malmgren, 1952).
Identification of hyaluronic acid.
The remaining polysaccharide material D had a similar chemical composition
and electrophoretic mobihty to hyaluronate from mammahan sources. D was
also degradedby testishyaluronidase at a similar rate to other suchhyaluronates.
Following acid hvdrolvsis onl glucose (glucosamine) could be demonstrated by
paper electrophoresis in borate buffer (Consden and Stanier, 1952). In addition,
infra-red spectral measurements kindly performed by S. F. D. Orr have show-n
the spectrum of sample D to be very similar to that of purified hyaluronate
prepared from human umbilical cord. (Orr, Harris and Sylve'n, 1952). The two
spectra were identical in the region 680-980 cm.-', showing the two materials
to have the same molecular skeleton (Orr, 1954). The only difference lay in
the relative intensities of the bands due to the acid and amide carbonyl groups.
However, the acid : amide ratio in sample D cannot be more than 5 per cent
greater than that in the purified umbilical hyaluronate.
Nature ofthe_8UIphur-containing material.
The metachromatic precipitate formed by Azure A treatment of sample B
was almost insoluble and further information about its composition could not
be obtained. Attempts were therefore made to remove the nucleic acid and the
hyaluronate from the starting material by successive ribonuclease and hyaluro-
nidase treatments. After removal of the hydrolysis products by dialysis it was
thought possible to obtain the S-bearing material in a purified and soluble state.
However, this latter material exhibited a powerful inhibitory effect on hyaluro-
nidase. In one experiment, when 30 mg. ofsample B was treated with 3 mg. of
testis hyaluronidabe (Wyeth, Inc.) in barbiturate buffer at pH 6-8 and 37' C.
for 3 days, more than 60 per cent ofthe substrate B still remained in anondialy-
sable state. The S content of the remaining non-digested material was 0-49 per
cent. In the course of this long digestion, however, a small precipitate was
formed, which had a N content of 10-0 per cent and S content of 4-8 per cent.
These figures suggested that a new product had been formed between the protein
hyaluronidase and a S-containing polysaccharide. If the polysaccharide is
assumed to contain 3 per cent nitrogen, the nitrogen value of the precipitate
would fit a protein content of about 55 per cent, and hence a polybaccharide
content of about 45 per cent. The sulphur value of 4-8 per cent would thus
indicate a polysaccharide containing about 10 per cent sulphur. The precipitate
mentioned above was shghtly soluble in alkaline media, and showed an anti-
thrombic activity coffesponding to about 10 to 20 per cent by weight ofheparin.
Thisfinding, inconjunction withthehigh S value and thehyaluronidaseinhibitory
effect suggest that heparin very likely represents the S-bearing material. ItFOLYSACCHARIDES OF ROUS SARCOMA NO. 1 145
should further be added thatsamples A to D were entirely without anti-thrombic
activity.
DISCUSSION.
FoRowing very mild extraction of Rous tumour tissue, a polysaccharide
material was obtained in combination with protein and ribosenucleic acid which
were easily removed enzymaticaRy. The intermediate protein-free material
(sample A) contained about 70 per cent hyaluronate, 25 per cent nucleic acid,
and about 5 per cent of a sulphur-be'aring polysaccharide presenting some bio-
logical characteristics ofheparin. Thelargestpart ofthepolysaccharide material
present is thus beyond doubt hyaluronic acid with identical molar characteristics
withthat obtainedfrommammahan sources. TheRoushyaluronatehasprobably
a lower particle size than the hyaluronate from normal tissues, and the high
viscosity of the intercellular Rous material seems partly due to the protein com-
ponents.
The identification of heparin in the sulphur-bearing polysaccharide has not
been fuRy established. The marked inhibitory action on hyaluronidase favours
theassumption thatheparin wasactuaRypresent. A furtherpossibihty may also
be considered, namely, that the antithrombic heparin assay was interfered with
by the simultaneous presence ofother materialreacting with the heparm comple-
ment or with thrombin. This question requires further study.
So far as the locahzation ofthese substances in Rous tumour tissue is concern-
ed it seems evident that hyaluronate, together with protein and salts, is present
in the intercellular ground substance. This view is supported by metachromatic
staining andbydigestionexperiments. Since the stromal areas of Rous sarcoma
are very poor in mast cells, and further, since the degree of metachromasia of
this ground substance is more pronounced than would be expected from the con-
tent of hyaluronic acid alone (Sylve'n and Malmgren, 1952), it would seem pro-
bable that part of the extracted heparin or heparin-like material is derived from
the ground substance.
SU3131&RY.
Extraction experiments confirm that Rous No. I fowl sarcoma tissue is rich
in hyaluronate, which presents chemical and infra-red characteristics identical
with mammahan hyaluronate. In addition, a smaR amount of another sulphur-
bearing polysaccharide has been demonstrated, which is beheved to be heparin.
The staining properties of Rous tumour tissue suggest that these polysaccharides
are most hkely located in the stromal ground substance.
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